227 related articles for article (PubMed ID: 10753446)
1. Modeling retrovirus production for gene therapy. 1. Determination Of optimal bioreaction mode and harvest strategy.
Cruz PE; Almeida JS; Murphy PN; Moreira JL; Carrondo MJ
Biotechnol Prog; 2000; 16(2):213-21. PubMed ID: 10753446
[TBL] [Abstract][Full Text] [Related]
2. Modeling retrovirus production for gene therapy. 2. Integrated optimization of bioreaction and downstream processing.
Cruz PE; Gonçalves D; Almeida J; Moreira JL; Carrondo MJ
Biotechnol Prog; 2000; 16(3):350-7. PubMed ID: 10835234
[TBL] [Abstract][Full Text] [Related]
3. Experimental and modelling study of different process modes for retroviral production in a fixed bed reactor.
Nehring D; Gonzalez R; Pörtner R; Czermak P
J Biotechnol; 2006 Mar; 122(2):239-53. PubMed ID: 16298006
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of retrovirus production and decay.
Le Doux JM; Davis HE; Morgan JR; Yarmush ML
Biotechnol Bioeng; 1999 Jun; 63(6):654-62. PubMed ID: 10397822
[TBL] [Abstract][Full Text] [Related]
5. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
[TBL] [Abstract][Full Text] [Related]
6. Process parameter shifting: Part II. Biphasic cultivation-A tool for enhancing the volumetric productivity of batch processes using Epo-Fc expressing CHO cells.
Trummer E; Fauland K; Seidinger S; Schriebl K; Lattenmayer C; Kunert R; Vorauer-Uhl K; Weik R; Borth N; Katinger H; Müller D
Biotechnol Bioeng; 2006 Aug; 94(6):1045-52. PubMed ID: 16736532
[TBL] [Abstract][Full Text] [Related]
7. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor.
Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A
Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907
[TBL] [Abstract][Full Text] [Related]
8. Maximizing interferon-gamma production by Chinese hamster ovary cells through temperature shift optimization: experimental and modeling.
Fox SR; Patel UA; Yap MG; Wang DI
Biotechnol Bioeng; 2004 Jan; 85(2):177-84. PubMed ID: 14705000
[TBL] [Abstract][Full Text] [Related]
9. A systems approach to plant bioprocess optimization.
Cloutier M; Chen J; De Dobbeleer C; Perrier M; Jolicoeur M
Plant Biotechnol J; 2009 Dec; 7(9):939-51. PubMed ID: 19843248
[TBL] [Abstract][Full Text] [Related]
10. High cell density fed batch and perfusion processes for stable non-viral expression of secreted alkaline phosphatase (SEAP) using insect cells: comparison to a batch Sf-9-BEV system.
Jardin BA; Montes J; Lanthier S; Tran R; Elias C
Biotechnol Bioeng; 2007 Jun; 97(2):332-45. PubMed ID: 17054119
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of retroviral production systems using quantitative analysis.
Kwon YJ; Peng CA
Biotechnol Prog; 2003; 19(2):528-37. PubMed ID: 12675597
[TBL] [Abstract][Full Text] [Related]
12. High-titer adenovirus vector production in 293S cell perfusion culture.
Cortin V; Thibault J; Jacob D; Garnier A
Biotechnol Prog; 2004; 20(3):858-63. PubMed ID: 15176892
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different bioreactor systems for the production of high titer retroviral vectors.
Merten OW; Cruz PE; Rochette C; Geny-Fiamma C; Bouquet C; Gonçalves D; Danos O; Carrondo MJ
Biotechnol Prog; 2001; 17(2):326-35. PubMed ID: 11312711
[TBL] [Abstract][Full Text] [Related]
14. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.
Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H
J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733
[TBL] [Abstract][Full Text] [Related]
15. Simpler noninstrumented batch and semicontinuous cultures provide mammalian cell kinetic data comparable to continuous and perfusion cultures.
Henry O; Kwok E; Piret JM
Biotechnol Prog; 2008; 24(4):921-31. PubMed ID: 19194901
[TBL] [Abstract][Full Text] [Related]
16. Impact of cell culture process changes on endogenous retrovirus expression.
Brorson K; De Wit C; Hamilton E; Mustafa M; Swann PG; Kiss R; Taticek R; Polastri G; Stein KE; Xu Y
Biotechnol Bioeng; 2002 Nov; 80(3):257-67. PubMed ID: 12226857
[TBL] [Abstract][Full Text] [Related]
17. Improvement of a mammalian cell culture process by adaptive, model-based dialysis fed-batch cultivation and suppression of apoptosis.
Frahm B; Lane P; Märkl H; Pörtner R
Bioprocess Biosyst Eng; 2003 Nov; 26(1):1-10. PubMed ID: 14505167
[TBL] [Abstract][Full Text] [Related]
18. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
Tang YJ; Ohashi R; Hamel JF
Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
[TBL] [Abstract][Full Text] [Related]
19. Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells.
Galbraith DJ; Tait AS; Racher AJ; Birch JR; James DC
Biotechnol Prog; 2006; 22(3):753-62. PubMed ID: 16739959
[TBL] [Abstract][Full Text] [Related]
20. Biotechnological aspects of the production of the anticancer drug podophyllotoxin.
Farkya S; Bisaria VS; Srivastava AK
Appl Microbiol Biotechnol; 2004 Oct; 65(5):504-19. PubMed ID: 15378293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
